nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are drug targets missed owing to lack of physical activity? – Reply
|
Gurwitz, David |
|
2001 |
6 |
11 |
p. 564- 1 p. |
artikel |
2 |
Automation of measurements and data evaluation in biomolecular NMR screening
|
Ross, Alfred |
|
2001 |
6 |
11 |
p. 583-593 11 p. |
artikel |
3 |
Challenges and new approaches for the vaccine industry
|
Bachmann, Martin F |
|
2001 |
6 |
11 |
p. 566-568 3 p. |
artikel |
4 |
High-throughput metabolism: making the most of the technology
|
Smith, Dennis |
|
2001 |
6 |
11 |
p. 564- 1 p. |
artikel |
5 |
Monitor: molecules and profiles
|
Barrett, David |
|
2001 |
6 |
11 |
p. 594-595 2 p. |
artikel |
6 |
Neural transplantation therapies for Parkinson's and Huntington's diseases
|
Barker, Roger A |
|
2001 |
6 |
11 |
p. 575-582 8 p. |
artikel |
7 |
News in brief
|
Ramster, Ben |
|
2001 |
6 |
11 |
p. 557-559 3 p. |
artikel |
8 |
Opportunities and strategies for introducing pharmacogenetics into early drug development
|
Chamberlain, John C. |
|
2001 |
6 |
11 |
p. 569-574 6 p. |
artikel |
9 |
People
|
Lawrence, Rebecca N |
|
2001 |
6 |
11 |
p. 560- 1 p. |
artikel |
10 |
Private prescription: Science fiction – fictional science?
|
Rowe, Raymond C |
|
2001 |
6 |
11 |
p. 561-562 2 p. |
artikel |
11 |
Pyrazolo[1,5-a]pyrimidines as novel COX-2 selective inhibitors
|
Barlocco, Daniela |
|
2001 |
6 |
11 |
p. 595- 1 p. |
artikel |
12 |
Reversing DNA damage from the sun
|
Whelan, Jo |
|
2001 |
6 |
11 |
p. 555-556 2 p. |
artikel |
13 |
Stealthy polymers target drug-resistant tumour cells
|
Owens, Joanna |
|
2001 |
6 |
11 |
p. 551-552 2 p. |
artikel |
14 |
Temperature-sensitive gels: from tissue engineering to drug delivery
|
Habeck, Martina |
|
2001 |
6 |
11 |
p. 553-554 2 p. |
artikel |
15 |
Value your compound management team!
|
Ray, Brenda Johnson |
|
2001 |
6 |
11 |
p. 563- 1 p. |
artikel |